UBS Group
XAGE

UBS Group’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

UBS Group’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,012
Closed -$20.2K – 11289
2025
Q2 		$20.2K Buy
8,012
+7,471
+1,381% +$27.3K ﹤0.01% 8432
2025
Q1 		$2.03K Sell
541
-585
-52% -$5.68K ﹤0.01% 9411
2024
Q4 		$9.42K Buy
1,126
+717
+175% +$6.81K ﹤0.01% 8361
2024
Q3 		$4.94K Buy
+409
New +$11.2K ﹤0.01% 8108
2024
Q1 		– Sell
-23
Closed -$2.63K – 10158
2023
Q4 		$2.63K Buy
+23
New +$1.97K ﹤0.01% 8083
2023
Q2 		– Sell
-77
Closed -$23.3K – 9813
2023
Q1 		$23.3K Buy
77
+69
+863% +$20.8K ﹤0.01% 6971
2022
Q4 		$2.5K Sell
8
-34
-81% -$10K ﹤0.01% 9666
2022
Q3 		$12K Hold
42
– – ﹤0.01% 8196
2022
Q2 		$12K Hold
42
– – ﹤0.01% 7691
2022
Q1 		$12K Buy
+42
New +$12.2K ﹤0.01% 8206

Other funds holding XAGE

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
CMU
Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

UBS Group's XAGE Position: Q3 2025 in Review

UBS Group sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2025, closing a stake of 8,012 shares — an estimated $20.2K sold.

UBS Group first reported a position in XAGE in Q1 2022 and held it in 10 quarters. The position peaked at $23.3K in Q1 2023. 3 funds tracked by Wall St. Rank hold XAGE as of Q3 2025.

  • UBS Group reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • UBS Group sold 8,012 Longevity Health Holdings, Inc. Common Stock shares in Q3 2025, an estimated $20.2K.
  • UBS Group first reported a position in Longevity Health Holdings, Inc. Common Stock in Q1 2022 and held it in 10 quarters.
  • UBS Group's Longevity Health Holdings, Inc. Common Stock position peaked at $23.3K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.